English | Español
Patient Daily | Apr 23, 2026

Taxpayers Protection Alliance director says 340B program raises costs for patients and taxpayers
Patient Daily | Apr 23, 2026

Ohio State celebrates organ transplants through Buckeyes for Life program
Patient Daily | Apr 23, 2026

Biotech layoffs may drive global movement of life sciences professionals
Patient Daily | Apr 23, 2026

Johnson & Johnson announces $24.1 billion in sales and targets $100 billion revenue in 2026
Patient Daily | Apr 23, 2026

Takeda ends partnership with Veritas In Silico after three years of research
Patient Daily | Apr 23, 2026

Bristol Myers Squibb spinout Beeline Medicines launches with $300 million and five assets
Patient Daily | Apr 23, 2026

FDA requests more data on safety of Lilly’s new obesity pill Foundayo
Patient Daily | Apr 23, 2026

Researchers report semaglutide improves liver function independently of weight loss

Trending
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Insmed ends skin disease drug development after trial results fall short
+ Regulatory
Patient Daily | Apr 16, 2026

Health Analyst: Abuse of 340b drug discount program ‘leaves patients stuck in the middle’

+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Roche and C4 Therapeutics announce new molecular glue partnership worth up to $1 billion
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Kailera Therapeutics announces potential $533 million IPO in obesity drug market